Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global ER Targeted Drugs for Breast Cancer Market Size Growth Rate by Type (2014-2025) 1.4.2 Tamoxifen 1.4.3 Toremifene 1.4.4 Fulvestrant 1.5 Market by Application 1.5.1 Global ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Drug Center 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 ER Targeted Drugs for Breast Cancer Market Size 2.2 ER Targeted Drugs for Breast Cancer Growth Trends by Regions 2.2.1 ER Targeted Drugs for Breast Cancer Market Size by Regions (2014-2025) 2.2.2 ER Targeted Drugs for Breast Cancer Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 ER Targeted Drugs for Breast Cancer Market Size by by Players 3.1.1 Global ER Targeted Drugs for Breast Cancer Revenue by by Players (2014-2019) 3.1.2 Global ER Targeted Drugs for Breast Cancer Revenue Market Share by by Players (2014-2019) 3.1.3 Global ER Targeted Drugs for Breast Cancer Market Concentration Ratio (CR5 and HHI) 3.2 ER Targeted Drugs for Breast Cancer Key Players Head office and Area Served 3.3 Key Players ER Targeted Drugs for Breast Cancer Product/Solution/Service 3.4 Date of Enter into ER Targeted Drugs for Breast Cancer Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) 4.2 Global ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) 5 United States 5.1 United States ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 5.2 ER Targeted Drugs for Breast Cancer Key Players in United States 5.3 United States ER Targeted Drugs for Breast Cancer Market Size by Type 5.4 United States ER Targeted Drugs for Breast Cancer Market Size by Application 6 Europe 6.1 Europe ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 6.2 ER Targeted Drugs for Breast Cancer Key Players in Europe 6.3 Europe ER Targeted Drugs for Breast Cancer Market Size by Type 6.4 Europe ER Targeted Drugs for Breast Cancer Market Size by Application 7 China 7.1 China ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 7.2 ER Targeted Drugs for Breast Cancer Key Players in China 7.3 China ER Targeted Drugs for Breast Cancer Market Size by Type 7.4 China ER Targeted Drugs for Breast Cancer Market Size by Application 8 Japan 8.1 Japan ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 8.2 ER Targeted Drugs for Breast Cancer Key Players in Japan 8.3 Japan ER Targeted Drugs for Breast Cancer Market Size by Type 8.4 Japan ER Targeted Drugs for Breast Cancer Market Size by Application 9 Southeast Asia 9.1 Southeast Asia ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 9.2 ER Targeted Drugs for Breast Cancer Key Players in Southeast Asia 9.3 Southeast Asia ER Targeted Drugs for Breast Cancer Market Size by Type 9.4 Southeast Asia ER Targeted Drugs for Breast Cancer Market Size by Application 10 India 10.1 India ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 10.2 ER Targeted Drugs for Breast Cancer Key Players in India 10.3 India ER Targeted Drugs for Breast Cancer Market Size by Type 10.4 India ER Targeted Drugs for Breast Cancer Market Size by Application 11 Central & South America 11.1 Central & South America ER Targeted Drugs for Breast Cancer Market Size (2014-2019) 11.2 ER Targeted Drugs for Breast Cancer Key Players in Central & South America 11.3 Central & South America ER Targeted Drugs for Breast Cancer Market Size by Type 11.4 Central & South America ER Targeted Drugs for Breast Cancer Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 ER Targeted Drugs for Breast Cancer Introduction 12.1.4 AstraZeneca Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.1.5 AstraZeneca Recent Development 12.2 Sanofi 12.2.1 Sanofi Company Details 12.2.2 Company Description and Business Overview 12.2.3 ER Targeted Drugs for Breast Cancer Introduction 12.2.4 Sanofi Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.2.5 Sanofi Recent Development 12.3 Pfizer 12.3.1 Pfizer Company Details 12.3.2 Company Description and Business Overview 12.3.3 ER Targeted Drugs for Breast Cancer Introduction 12.3.4 Pfizer Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.3.5 Pfizer Recent Development 12.4 Mylan  12.4.1 Mylan  Company Details 12.4.2 Company Description and Business Overview 12.4.3 ER Targeted Drugs for Breast Cancer Introduction 12.4.4 Mylan  Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.4.5 Mylan  Recent Development 12.5 Wockhardt 12.5.1 Wockhardt Company Details 12.5.2 Company Description and Business Overview 12.5.3 ER Targeted Drugs for Breast Cancer Introduction 12.5.4 Wockhardt Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.5.5 Wockhardt Recent Development 12.6 Cipla 12.6.1 Cipla Company Details 12.6.2 Company Description and Business Overview 12.6.3 ER Targeted Drugs for Breast Cancer Introduction 12.6.4 Cipla Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.6.5 Cipla Recent Development 12.7 Actiza Pharmaceutical 12.7.1 Actiza Pharmaceutical Company Details 12.7.2 Company Description and Business Overview 12.7.3 ER Targeted Drugs for Breast Cancer Introduction 12.7.4 Actiza Pharmaceutical Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.7.5 Actiza Pharmaceutical Recent Development 12.8 Teva 12.8.1 Teva Company Details 12.8.2 Company Description and Business Overview 12.8.3 ER Targeted Drugs for Breast Cancer Introduction 12.8.4 Teva Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.8.5 Teva Recent Development 12.9 Shanghai Forward Technology 12.9.1 Shanghai Forward Technology Company Details 12.9.2 Company Description and Business Overview 12.9.3 ER Targeted Drugs for Breast Cancer Introduction 12.9.4 Shanghai Forward Technology Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.9.5 Shanghai Forward Technology Recent Development 12.10 Bayer 12.10.1 Bayer Company Details 12.10.2 Company Description and Business Overview 12.10.3 ER Targeted Drugs for Breast Cancer Introduction 12.10.4 Bayer Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) 12.10.5 Bayer Recent Development 12.11 Liaoning Kangtai Pharmaceutical 12.12 Fu 'an Pharmaceutical Group 12.13 Yangtze River Pharmaceutical Group 12.14 Amneal Pharms 12.15 Novartis 12.16 Intas Pharmaceuticals 12.17 Chemo 12.18 Accure Labs 12.19 Natco 12.20 Orion Corporation 12.21 Kyowa Hakko Kirin 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table ER Targeted Drugs for Breast Cancer Key Market Segments Table Key Players ER Targeted Drugs for Breast Cancer Covered Table Global ER Targeted Drugs for Breast Cancer Market Size Growth Rate by Type 2019-2025 (Million US$) Figure Global ER Targeted Drugs for Breast Cancer Market Share by TypeType in 2018 & 2025 Figure Tamoxifen Figures Table Key Players of Tamoxifen Figure Toremifene Figures Table Key Players of Toremifene Figure Fulvestrant Figures Table Key Players of Fulvestrant Table Global ER Targeted Drugs for Breast Cancer Market Size Growth by Application 2019-2025 (Million US$) Figure Global ER Targeted Drugs for Breast Cancer Market Share by Application in 2018 & 2025 Figure Hospital Case Studies Figure Clinic Case Studies Figure Drug Center Case Studies Figure Other Case Studies Figure ER Targeted Drugs for Breast Cancer Report Years Considered Table Global ER Targeted Drugs for Breast Cancer Market Size 2014-2025 (Million US$) Figure Global ER Targeted Drugs for Breast Cancer Market Size and Growth Rate 2014-2025 (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Size by Regions 2019-2025 (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Size by Regions 2019-2025 (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Share by Regions 2014-2019 Figure Global ER Targeted Drugs for Breast Cancer Market Share by Regions 2014-2019 Figure Global ER Targeted Drugs for Breast Cancer Market Share by Regions 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global ER Targeted Drugs for Breast Cancer Revenue by by Players (2014-2019) (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Share by by Players (2014-2019) Figure Global ER Targeted Drugs for Breast Cancer Market Share by by Players in 2018 Table Global ER Targeted Drugs for Breast Cancer by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players ER Targeted Drugs for Breast Cancer Product/Solution/Service Table Date of Enter into ER Targeted Drugs for Breast Cancer Market Table Mergers & Acquisitions, Expansion Plans Table Global ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Size Share by Type (2014-2019) Figure Global ER Targeted Drugs for Breast Cancer Market Size Market Share by Type (2014-2019) Table Global ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Global ER Targeted Drugs for Breast Cancer Market Size Share by Application (2014-2019) Figure Global ER Targeted Drugs for Breast Cancer Market Size Market Share by Application (2014-2019) Figure Global ER Targeted Drugs for Breast Cancer Revenue Market Share by Application in 2018 Figure United States ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table United States Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table United States Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table United States ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table United States ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table United States ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table United States ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure Europe ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table Europe Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table Europe Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table Europe ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Europe ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table Europe ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Europe ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure China ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table China Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table China Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table China ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table China ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table China ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table China ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure Japan ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table Japan Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table Japan Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table Japan ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Japan ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table Japan ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Japan ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure Southeast Asia ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table Southeast Asia ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Southeast Asia ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table Southeast Asia ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Southeast Asia ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure India ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table India Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table India Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table India ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table India ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table India ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table India ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Figure Central & South America ER Targeted Drugs for Breast Cancer Market Size 2014-2019 (Million US$) Table Central & South America Key Players ER Targeted Drugs for Breast Cancer Revenue (2018-2019) (Million US$) Table Central & South America Key Players ER Targeted Drugs for Breast Cancer Market Share (2018-2019) Table Central & South America ER Targeted Drugs for Breast Cancer Market Size by Type (2014-2019) (Million US$) Table Central & South America ER Targeted Drugs for Breast Cancer Market Share by Type (2014-2019) Table Central & South America ER Targeted Drugs for Breast Cancer Market Size by Application (2014-2019) (Million US$) Table Central & South America ER Targeted Drugs for Breast Cancer Market Share by Application (2014-2019) Table AstraZeneca Company Details Table AstraZeneca Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019) (Million US$) Figure AstraZeneca Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table AstraZeneca Recent Development Table Sanofi Company Details Table Sanofi Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Sanofi Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Sanofi Recent Development Table Pfizer Company Details Table Pfizer Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Pfizer Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Pfizer Recent Development Table Mylan  Company Details Table Mylan  Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Mylan  Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Mylan  Recent Development Table Wockhardt Company Details Table Wockhardt Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Wockhardt Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Wockhardt Recent Development Table Cipla Company Details Table Cipla Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Cipla Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Cipla Recent Development Table Actiza Pharmaceutical Company Details Table Actiza Pharmaceutical Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Actiza Pharmaceutical Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Actiza Pharmaceutical Recent Development Table Teva Company Details Table Teva Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Teva Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Teva Recent Development Table Shanghai Forward Technology Company Details Table Shanghai Forward Technology Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Shanghai Forward Technology Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Shanghai Forward Technology Recent Development Table Bayer Company Details Table Bayer Revenue in ER Targeted Drugs for Breast Cancer Business (2014-2019)(Million US$) Figure Bayer Revenue Growth Rate in ER Targeted Drugs for Breast Cancer Business (2014-2019) Table Bayer Recent Development Table Liaoning Kangtai Pharmaceutical Company Details Table Fu 'an Pharmaceutical Group Company Details Table Yangtze River Pharmaceutical Group Company Details Table Amneal Pharms Company Details Table Novartis Company Details Table Intas Pharmaceuticals Company Details Table Chemo Company Details Table Accure Labs Company Details Table Natco Company Details Table Orion Corporation Company Details Table Kyowa Hakko Kirin Company Details Table Global ER Targeted Drugs for Breast Cancer Market Size by Regions (Million US$) 2019-2025 Figure Global ER Targeted Drugs for Breast Cancer Market Size Share by Regions (2019-2025) Figure Global ER Targeted Drugs for Breast Cancer Market Size Share by Regions in 2025 Figure United States ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Europe ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure China ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Japan ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure India ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Figure Central & South America ER Targeted Drugs for Breast Cancer Market Size Forecast (2019-2025)(Million USD) Table Global ER Targeted Drugs for Breast Cancer Market Size by Product (2019-2025) (Million US$) Figure Global ER Targeted Drugs for Breast Cancer Market Size by Product (2019-2025) Figure Global ER Targeted Drugs for Breast Cancer Market Size by Product in 2025 Table Global ER Targeted Drugs for Breast Cancer Market Size by Application (2019-2025) (Million US$) Figure Global ER Targeted Drugs for Breast Cancer Market Size by Application (2019-2025) Figure Global ER Targeted Drugs for Breast Cancer Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Sanofi Pfizer Mylan  Wockhardt Cipla Actiza Pharmaceutical Teva Shanghai Forward Technology Bayer Liaoning Kangtai Pharmaceutical Fu 'an Pharmaceutical Group Yangtze River Pharmaceutical Group Amneal Pharms Novartis Intas Pharmaceuticals Chemo Accure Labs Natco Orion Corporation Kyowa Hakko Kirin